Durable Clinical Benefit of B-Cell Maturation Antigen-Directed Therapy With Belantamab Mafodotin Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: DREAMM-8 Long-Term Responder Analysis

  • Dimopoulos, Meletios A.; 
  • Beksac, Meral; 
  • Delimpasi, Sosana; 
  • Vorobyev, Vladimir; 
  • Quach, Hang; 
  • ... Kim, Kihyun; 
  • 외 13명
Citations

WEB OF SCIENCE

0

키워드

MM; DREAMM-8; B-cell maturation antigen; antibody-drug conjugate; subgroup analysis; phase 3
제목
Durable Clinical Benefit of B-Cell Maturation Antigen-Directed Therapy With Belantamab Mafodotin Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: DREAMM-8 Long-Term Responder Analysis
저자
Dimopoulos, Meletios A.; Beksac, Meral; Delimpasi, Sosana; Vorobyev, Vladimir; Quach, Hang; Spic, Ivan; Radocha, Jakub; Robak, Pawel; Kim, Kihyun; Cavo, Michele; Zafar, Syed; Moore, Ainslee; Morris, Kristin; Polinkovsky, Margaret; Brock, Kelly; Grams, Joanna; Manasanch, Elisabet; Mateos, Maria-Victoria; Trudel, Suzanne
발행일
2026-08
유형
Meeting Abstract
저널명
Clinical Lymphoma, Myeloma and Leukemia
권
26
페이지
S1058 ~ S1059